Authors:
Reber, G
Bounameaux, H
Perrier, A
de Moerloose, P
Citation: G. Reber et al., Performances of a new, automated latex assay for the exclusion of venous thromboembolism, BL COAG FIB, 12(3), 2001, pp. 217-220
Authors:
Galle, C
Papazyan, JP
Miron, MJ
Slosman, D
Bounameaux, H
Perrier, A
Citation: C. Galle et al., Prediction of pulmonary embolism extent by clinical findings, D-dimer level and deep vein thrombosis shown by ultrasound, THROMB HAEM, 86(5), 2001, pp. 1156-1160
Authors:
Righini, M
de Moerloose, P
Reber, G
Perrier, A
Bounameaux, H
Citation: M. Righini et al., Should the D-dimer cut-off value be increased in elderly patients suspected of pulmonary embolism?, THROMB HAEM, 85(4), 2001, pp. 744-744
Citation: Jj. Michiels et al., Should a normal D-dimer rule out angiographic pulmonary embolism or unfavorable outcome in patients left untreated?, THROMB HAEM, 85(4), 2001, pp. 753-753
Citation: A. Bigaroni et al., Is clinical probability assessment of deep vein thrombosis by a score really standardized? (vol 83, pg 788, 2000), THROMB HAEM, 85(3), 2001, pp. 576-576
Authors:
de Moerloose, P
Bounameaux, H
Perrier, A
Reber, G
Citation: P. De Moerloose et al., Performances of the VIDAS D-dimer new assay for the exclusion of venous thromboembolism, THROMB HAEM, 85(1), 2001, pp. 185-186
Citation: A. Perrier et H. Bounameaux, Diagnosis of pulmonary embolism in outpatients by sequential noninvasive tools, SEM THROMB, 27(1), 2001, pp. 25-32
Citation: A. Perrier et al., Introduction of D-dimer assay: Does it increase resource utilization or correct identification of pulmonary embolism?, ARCH IN MED, 161(16), 2001, pp. 2049-2050
Authors:
Wicki, J
Perneger, TV
Junod, AF
Bounameaux, H
Perrier, A
Citation: J. Wicki et al., Assessing clinical probability of pulmonary embolism in the emergency ward- A simple score, ARCH IN MED, 161(1), 2001, pp. 92-97
Authors:
Perrier, A
Howarth, N
Didier, D
Loubeyre, P
Unger, PF
de Moerloose, P
Slosman, D
Junod, A
Bounameaux, H
Citation: A. Perrier et al., Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism, ANN INT MED, 135(2), 2001, pp. 88-97
Citation: N. Perone et al., Comparison of four strategies for diagnosing deep vein thrombosis: A cost-effectiveness analysis, AM J MED, 110(1), 2001, pp. 33-40
Citation: H. Bounameaux et Eko. Kruithof, On the association of elevated tPA/PAI-1 complex and von Willebrand factorwith recurrent myocardial infarction, ART THROM V, 20(8), 2000, pp. 1857-1859
Authors:
Reber, G
Blanchard, J
Bounameaux, H
Hoffmeyer, P
Miron, MJ
Leyvraz, PF
de Moerloose, P
Citation: G. Reber et al., Inability of serial fibrin monomer measurements to predict or exclude deepvenous thrombosis in asymptomatic patients undergoing total knee arthroplasty, BL COAG FIB, 11(3), 2000, pp. 305-308
Citation: Mj. Miron et al., Clinical assessment of suspected deep vein thrombosis: comparison between a score and empirical assessment, J INTERN M, 247(2), 2000, pp. 249-254
Citation: A. Bigaroni et al., Is clinical probability assessment of deep vein thrombosis by a score really standardized?, THROMB HAEM, 83(5), 2000, pp. 788-789
Citation: Pf. Leyvraz et H. Bounameaux, Prevention of deep-vein thrombosis after total knee replacement - Reply, J BONE-BR V, 82B(2), 2000, pp. 304-305
Authors:
Bongard, O
Weimer, D
Lemoine, R
Bolle, JF
Leski, M
Bounameaux, H
Citation: O. Bongard et al., Cyclosporine toxicity in renal transplant recipients detected by nailfold capillaroscopy with Na-fluorescein, KIDNEY INT, 58(6), 2000, pp. 2559-2563
Authors:
Buller, HR
Cariou, R
Gallus, A
Gent, M
Ginsberg, J
Prins, MH
Lensing, A
Levi, M
Nurmohammed, N
Hirsh, J
Roberts, R
ten Cate, JW
Decousus, H
Mismetti, P
Buchmuller, A
Charlet, V
Viallon, A
van der Meer, J
Meinardi, JR
Meijer, K
Piovella, F
Barone, M
Beltrametti, C
Serafini, S
Kraaijenhagen, RA
Koopman, MMW
Jagt, HHT
Muller, MBR
Kooy, MV
Nauta, S
Gallus, AS
Coghlan, D
Rich, C
Prandoni, P
Scudeller, A
Scarano, L
Girolami, A
Baker, R
Tan, E
Cooney, J
Eikelboom, J
Ninet, J
Dolmazon, C
Madoux, MHG
Coppere, B
Nenci, GG
Agnelli, G
Falcinelli, F
Morini, M
d'Angelo, A
Crippa, L
d'Angelo, SV
Chong, B
Chestreman, C
Malvin, J
Eisbacher, M
MacGillavry, MR
Brandjes, DPM
Beaumont, JFM
Olmos, RAV
Turpie, AGG
Johnson, J
Nowacki, B
Anderson, D
Pleasance, S
Mitchell, M
Ockelford, P
Bennett, A
Jones, R
Porteous, F
Weitz, J
Kearon, C
Simonneau, G
Parent, F
Douketis, J
Schnurr, T
Hainaut, P
Petit, B
Jaumotte, C
Huisman, MV
van Poelgeest, MIE
Meinders, AE
van Oostayen, JA
Beer, J
Lugli, A
Pederiva, S
Ginsberg, J
Brill-Edwards, P
Stevens, P
Bassand, JP
Seronde, MF
Kassis, J
Fortin, M
Faivre, R
Petiteau, PY
Verhaeghe, R
Wells, P
Lewandowski, B
Touchie, D
Banga, JD
Hartmann, IJC
Zeguers, VJM
Desjardins, L
Villeneuve, J
Cote, J
Bounameaux, H
Cirafici, P
Demers, C
van der Heul, C
Kruip, M
Citation: Hr. Buller et al., Treatment of proximal deep vein thrombosis with a novel synthetic compound(SR90107A/ORG31540) with pure anti-factor Xa activity - A phase II evaluation, CIRCULATION, 102(22), 2000, pp. 2726-2731
Authors:
de Moerloose, P
Reber, G
Perrier, A
Perneger, T
Bounameaux, H
Citation: P. De Moerloose et al., Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism, BR J HAEM, 110(1), 2000, pp. 125-129